Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United KingdomIrelandUnited States (current)New ZealandCanadaAustraliaScotlandNorthern Ireland

← US public companies

Glickman Mark A

SEC-identified person · CIK 1441461 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Neurobo Pharmaceuticals, Inc. NRBO Director filed 2023–2026
Therapeuticsmd, Inc. coff Co-Chief Executive Officer filed 2021–2022
Esperion Therapeutics, Inc. ESPR Chief Commercial Officer filed 2018–2020
Aralez Pharmaceuticals Inc. ARLZ Chief Commercial officer filed 2016–2018
Pozen INC /NC POZN Chief Commercial Officer filed 2015–2015
Auxilium Pharmaceuticals INC AUXL SVP - Sales filed 2012–2015
Oscient Pharmaceuticals Corp OSCI SVP, Sales & Marketing filed 2008–2008

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.